Top News
Home >> Marketplace Archives >> Agena, Simceredx to develop companion dx, 5/18

Agena, Simceredx to develop companion dx, 5/18

Print Friendly, PDF & Email


May 2018—Agena Bioscience and Simcere Diagnostics signed a strategic partnership agreement to expand the use of Agena’s Mass­Array System for companion diagnostics and pharmacogenetic testing in China.

Simceredx will develop panels to support companion diagnostics for its drug development pipelines in China’s hospital system. Simceredx will be supported by Agena’s sales team in China to commercialize Agena’s high-throughput, 384-well format automated system.

Agena Bioscience, 858-882-2800


Check Also

Multiplexed analysis to detect gene fusions, 5/17

May 2017—Agena Bioscience announced a comparative study published in Scientific Reports highlighting the use of its mass-spec-based platform for transcriptome analysis of ALK, ROS1, and RET gene fusions in lung cancer.